GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma

Authors

C. Oliver Hanemann, Peninsula Medical School
Caterina Negroni
David A. Hilton, University Hospitals Plymouth NHS Trust
Emanuela Ercolano, UoP RI - Plymouth Institute of Health and Care Research
Claire L. Adams, Peninsula Medical School
Kathreena M. Kurian, University of Bristol
Daniele Baiz

ORCID

• C. Oliver Hanemann: 0000-0002-1951-1025
• Claire L. Adams: 0000-0003-3871-9267

DOI Link

10.1016/j.ebiom.2020.102941

DOI

10.1016/j.ebiom.2020.102941

Publication Date

2020-01-01

Publication Title

eBioMedicine

Volume

59

Embargo Period

2020-10-03

First Page

102941

Last Page

102941

Recommended Citation

Hanemann, C., Negroni, C., Hilton, D., Ercolano, E., Adams, C., Kurian, K., & Baiz, D. (2020) 'GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma', eBioMedicine, 59, pp. 102941-102941. Available at: 10.1016/j.ebiom.2020.102941